These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9252380)

  • 41. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Measurement of reduction of disulfide bonds in plasmin by phosphoglycerate kinase.
    Lay AJ; Hogg PJ
    Methods Enzymol; 2002; 348():87-92. PubMed ID: 11885297
    [No Abstract]   [Full Text] [Related]  

  • 43. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases.
    Apte RS; Niederkorn JY; Mayhew E; Alizadeh H
    Arch Ophthalmol; 2001 Dec; 119(12):1805-9. PubMed ID: 11735791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. S-glutathiolated hepatocyte proteins and insulin disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein disulfide isomerase, and glutathione.
    Jung CH; Thomas JA
    Arch Biochem Biophys; 1996 Nov; 335(1):61-72. PubMed ID: 8914835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
    Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9).
    Patterson BC; Sang QA
    J Biol Chem; 1997 Nov; 272(46):28823-5. PubMed ID: 9360944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property.
    Nakagawa H; Yasuda S; Matsuura E; Kobayashi K; Ieko M; Kataoka H; Horita T; Atsumi T; Koike T
    Blood; 2009 Sep; 114(12):2553-9. PubMed ID: 19625706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo.
    Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM
    Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of recombinant human plasminogen in mammalian cells is augmented by suppression of plasmin activity.
    Busby SJ; Mulvihill E; Rao D; Kumar AA; Lioubin P; Heipel M; Sprecher C; Halfpap L; Prunkard D; Gambee J
    J Biol Chem; 1991 Aug; 266(23):15286-92. PubMed ID: 1831201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extrahepatic synthesis of plasminogen in the human cornea is up-regulated by interleukins-1alpha and -1beta.
    Twining SS; Wilson PM; Ngamkitidechakul C
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):705-12. PubMed ID: 10215610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiostatin expression in non-small cell lung cancer.
    Volm M; Mattern J; Koomägi R
    Clin Cancer Res; 2000 Aug; 6(8):3236-40. PubMed ID: 10955809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-tumor activity of a combination of plasminogen activator and captopril in a human melanoma xenograft model.
    de Groot-Besseling RR; Ruers TJ; van Kraats AA; Poelen GJ; Ruiter DJ; de Waal RM; Westphal JR
    Int J Cancer; 2004 Nov; 112(2):329-34. PubMed ID: 15352048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen).
    Goretzki L; Lombardo CR; Stallcup WB
    J Biol Chem; 2000 Sep; 275(37):28625-33. PubMed ID: 10889192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells.
    Tuszynski GP; Sharma MR; Rothman VL; Sharma MC
    Microvasc Res; 2002 Nov; 64(3):448-62. PubMed ID: 12453439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
    Wajih N; Sane DC
    Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human angiostatin inhibits murine hemangioendothelioma tumor growth in vivo.
    Lannutti BJ; Gately ST; Quevedo ME; Soff GA; Paller AS
    Cancer Res; 1997 Dec; 57(23):5277-80. PubMed ID: 9393749
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased angiostatin levels in bronchoalveolar lavage fluids from ARDS patients and from human volunteers after lung instillation of endotoxin.
    Luca R; Lijnen HR; Suffredini AF; Pepper MS; Steinberg KP; Martin TR; Pugin J
    Thromb Haemost; 2002 Jun; 87(6):966-71. PubMed ID: 12083503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-angiogenic role of angiostatin during corneal wound healing.
    Gabison E; Chang JH; Hernández-Quintela E; Javier J; Lu PC; Ye H; Kure T; Kato T; Azar DT
    Exp Eye Res; 2004 Mar; 78(3):579-89. PubMed ID: 15106938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells.
    Tarui T; Miles LA; Takada Y
    J Biol Chem; 2001 Oct; 276(43):39562-8. PubMed ID: 11514539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.
    de Groot-Besseling RR; Ruers TJ; Lamers-Elemans IL; Maass CN; de Waal RM; Westphal JR
    BMC Cancer; 2006 Jun; 6():149. PubMed ID: 16753063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.